Bringing the Oncology Community Together
Head & Neck
Dr. Gomella on Current Prostate Screening Procedures
Leonard G. Gomella, MD
Wednesday, March 30, 2011
In an interview at the 2011 IPCC Meeting in New York, Leonard G. Gomella, MD, from Jefferson Kimmel Cancer Center, discusses prostate cancer screening procedures.
SEE ALL VIDEOS FROM: Leonard G. Gomella, MD
Molecular Signature Distinguishes Indolent From Aggressive Prostate Cancer
Prostate cancer is one of the most common forms of cancer in older men, with more than 200,000 new diagnoses per year.
In Advanced Prostate Cancer, Degarelix Offers Advantages Over LHRH Agonists
Men with advanced prostate cancer who took the GnRH antagonist degarelix experienced improved disease control, fewer instances of urinary infections, and a lower risk of cardiovascular events than did those patients who took LHRH agonists.
Conclusion: Final Thoughts on Treating mCRPC
In the final clip of the discussion, panelists discusses the treatment of men with metastatic castration-resistant prostate cancer, as treatments continues to evolve and gain approval.
Dr. Kelly on Selecting Therapy for Patients with CRPC
Dr. Sawyers Accepts his “Giants of Cancer Care” Award
Dr. Yu on the Role of PET Imaging in Prostate Cancer
Most Popular Right Now
ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib
Quest Diagnostics Launches New BRCA 1/2 Test
Cost Challenges in Developing New Oncology Drugs
Mammogram Study Provides Rationale for Expanding Screening Programs
Lymphoma Research Focuses on Targeting Genetic Drivers
Tweets by @OncLive
American Journal of Managed Care
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.